What is the Utility of distal forearm DXA in primary Hyperparathyroidism?

Oncologist

Volumn 17, Issue 3, 2012, Pages 322-325

  Wood, Kelly ^a   Dhital, Subarna ^a   Chen, Herbert ^b   Sippel, Rebecca S ^b  

^a Department of Medicine   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Dual X ray absorptiometry; Forearm; Osteoporosis; Primary hyperparathyroidism

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; BONE DENSITY; COHORT ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FOREARM; FRAGILITY FRACTURE; HUMAN; LUMBAR SPINE; MALE; OSTEOPENIA; OSTEOPOROSIS; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RADIUS; RETROSPECTIVE STUDY; SCORING SYSTEM;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; FEMALE; FEMUR; FOREARM; HUMANS; HYPERPARATHYROIDISM, PRIMARY; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROIDECTOMY; RETROSPECTIVE STUDIES;

EID: 84859384884     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0285     Document Type: Article

References (16)

1. Lundgren E, Rastad J, Thrufjell E et al. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121: 287-294.
2. Grey A, Mitnick MA, Shapses S et al. Circulating levels of interleukin-6 and tumor necrosis factor-÷ are elevated in primary hyperparathyroidism and correlate with markers of bone resorption-a clinical research center study. J Clin Endocrinol Metab 1996;81:3450-3454.
3. Saleem TF, Horwith M, Stack BC Jr. Significance of primary hyperparathyroidism in the management of osteoporosis. Otolaryngol Clin North Am 2004;37:751-761, viii-ix.
4. Silverberg SJ, Shane E, Cruz L et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 1989;4:283-291.
5. Rao DS, Phillips ER, Divine GW et al. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 2004;89:5415-5422.
6. Silverberg SJ, Shane E, Jacobs TP et al. A 10year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;341:1249-1255.
7. Khosla S, Melton LJ 3rd, Wermers RA et al. Primary hyperparathyroidism and the risk of fracture: A population-based study. J Bone Miner Res 1999;14: 1700-1707.
8. Melton LJ 3rd, Atkinson EJ, O'Fallon WM et al. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 1992;152: 2269-2273.
9. Vestergaard P, Mollerup CL, Frkjaer VG et al. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 2000; 321:598-602.
10. Bilezikian JP, Khan AA, Potts JT Jr et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the third international workshop. J Clin Endocrinol Metab 2009;94:335-339.
11. Center J. R, Bliuc D, Nguyen TV et al. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 2007;297:387-394.
12. Grant CS, Thompson G, Farley D et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 2005;140: 472-478; discussion 478-479.
13. Eriksen EF. Primary hyperparathyroidism: Lessons from bone histomorphometry. J Bone Miner Res 2002;17(suppl 2):N95-N97.
14. Miller PD, Bilezikian JP. Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res 2002;17(suppl 2):N98-N102.
15. Silverberg SJ, Gartenberg F, Jacobs TP et al. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 1995;80:723-728.
16. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J Clin Endocrinol Metab 2002;87: 5353-5361.